ArticleFrontiers in pharmacology2026
Preparation of a chronic complete atrioventricular block rat model using myocardial surface radiofrequency ablation.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Research using rat models of chronic complete atrioventricular block (CAVB) remains limited, and several problems, particularly model instability, persist. This study aimed to optimize the method used to establish a CAVB rat model. The most suitable approach for establishing a CAVB rat model was selected from chemical ablation, myocardial invasive radiofrequency ablation, and myocardial surface radiofrequency ablation by comparing their success rates and stability. The findings indicate that myocardial surface radiofrequency ablation using a thin blunt tip is a reliable method for establishing a CAVB rat model, offering a high success rate, operational simplicity, and good stability. Moreover, myocardial surface radiofrequency ablation with a thin blunt tip achieved comparable success rates under two different parameter settings (20 W/5 s and 25 W/3 s). An appropriately sized contact tip should be selected to prevent accidental contact with the aorta. The ablation parameters can be adjusted according to the principle that lower power requires a longer ablation duration, whereas higher power permits a shorter duration. This CAVB rat model is important for further investigating the mechanisms underlying CAVB and developing more effective therapeutic interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.